2011

Chaulet C, Croix C, Alagille D, Normand S, Delwail A, Favot L, Lecron JC, Viaud-Massuard MC (2011) Design, synthesis and biological evaluation of new thalidomide analogues as TNF-alpha and IL-6 production inhibitors. Bioorg Med Chem Lett 21: 1019-1022

Chevalier F, Herbiniere-Gaboreau J, Bertaux J, Raimond M, Morel F, Bouchon D, Greve P, Braquart-Varnier C (2011) The immune cellular effectors of terrestrial isopod Armadillidium vulgare: meeting with their invaders, Wolbachia. PLoS One 6: e18531

Ghannam S, Dejou C, Pedretti N, Giot JP, Dorgham K, Boukhaddaoui H, Deleuze V, Bernard FX, Jorgensen C, Yssel H, Pene J (2011) CCL20 and beta-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions. J Immunol 186: 1411-1420

Jeru I, Hentgen V, Normand S, Duquesnoy P, Cochet E, Delwail A, Grateau G, Marlin S, Amselem S, Lecron JC (2011) Role of interleukin-1beta in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy. Arthritis Rheum 63: 2142-2148

Mogoa E, Bodet C, Morel F, Rodier MH, Legube B, Hechard Y (2011) Cellular response of the amoeba Acanthamoeba castellanii to chlorine, chlorine dioxide, and monochloramine treatments. Appl Environ Microbiol 77: 4974-4980

Tran TA, Pariente D, Lecron JC, Delwail A, Taoufik Y, Meinzer U (2011) Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs. Arthritis Rheum 63: 4031-4032

Recherche

Menu principal

Haut de page